Blank Bio Analysis
What is Blank Bio?
Blank Bio builds AI foundation models for RNA as an applied research lab. The company applies these models to precision oncology, including disease progression modeling and therapy response prediction. It says pharma teams use its system to identify trial candidates, study resistance mechanisms, and evaluate combination strategies.
Location
San Francisco, United States
Employees
1-10
Founded
2025
Industry
Healthcare, Therapeutics
AI Category
AI-native
YC Batch
S25
YC Partner
Ankit Gupta
Who are the founders of Blank Bio
Product Description
Blank Bio specializes in developing advanced foundation models for RNA therapeutics. Their main product offerings include a computational toolkit designed for various applications in RNA therapeutics, particularly focusing on mRNA design and cfRNA analysis.
Key features of their offerings include:
- mRNA Design Tools: These tools facilitate the design of mRNA sequences for therapeutic applications, enabling the development of RNA-based therapies.
- cfRNA Analysis: This feature allows for isoform-level functional characterization, which is crucial for understanding the roles of different RNA variants in biological processes.
- Novel Biomarker Discovery: The models assist in identifying new biomarkers that can be used in diagnostics and therapeutic monitoring.
- Target Identification: They provide capabilities for identifying potential targets for small molecule drugs that interact with RNA.
The benefits of using Blank Bio's products include accelerated development timelines for RNA therapeutics, improved patient outcomes through more effective therapies, and enhanced research capabilities for biopharmaceutical companies and research institutions focused on RNA biology.
See something that needs updating? Suggest edits to this profile.